These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11215774)

  • 1. The characteristics of mediastinal neuroblastoma.
    Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Ohgami H; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Tsuneyoshi M; Tasaka H; Yano H; Akiyama H; Ikeda K
    Eur J Pediatr Surg; 2000 Dec; 10(6):353-9. PubMed ID: 11215774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
    Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
    Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of infants with neuroblastoma detected by mass screening and surgically treated in Shiga Prefecture, Japan: what is the role of surgery?
    Hase T; Ohta S; Tani T; Mizukuro T; Mekata E; Naitoh H; Shimadera S; Fujino S; Taga T
    Pediatr Surg Int; 2002 Sep; 18(5-6):289-94. PubMed ID: 12415341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
    N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival for patients with advanced neuroblastoma after high-dose combined chemotherapy based in part on N-myc amplification.
    Suita S; Tajiri T; Sera Y; Takamatsu H; Mizote H; Nagasaki A; Kurosaki N; Hara T; Okamura J; Miyazaki S; Sugimoto T; Kawakami K; Eguchi H; Tsuneyoshi M
    J Pediatr Surg; 2000 Dec; 35(12):1737-41. PubMed ID: 11101726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
    Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYCN protein expression as a predictor of neuroblastoma prognosis.
    Chan HS; Gallie BL; DeBoer G; Haddad G; Ikegaki N; Dimitroulakos J; Yeger H; Ling V
    Clin Cancer Res; 1997 Oct; 3(10):1699-706. PubMed ID: 9815553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
    Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
    Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of malignant mediastinal neurogenic tumors in children.
    Kang CH; Kim YT; Jeon SH; Sung SW; Kim JH
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):725-30. PubMed ID: 17306984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the role of surgery in 25 patients with metastatic neuroblastoma].
    Nakadate H; Kishino T; Ogawa Y; Hatayama Y; Hatae Y; Takeda T; Naitoh H; Sasaki M
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1315-20. PubMed ID: 2369136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
    Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
    Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
    Martinsson T; Sjöberg RM; Hedborg F; Kogner P
    Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas.
    Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Iwai J; Shirasawa H; Simizu B
    Cancer Res; 1991 Jun; 51(12):3148-52. PubMed ID: 2039993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.
    Seeger RC; Brodeur GM; Sather H; Dalton A; Siegel SE; Wong KY; Hammond D
    N Engl J Med; 1985 Oct; 313(18):1111-6. PubMed ID: 4047115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical aspects of N-myc oncogene amplification of neuroblastoma.
    Nakagawara A; Ikeda K; Yokoyama T; Tsuda T; Higashi K
    Surgery; 1988 Jul; 104(1):34-40. PubMed ID: 3388178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification.
    Castle VP; Heidelberger KP; Bromberg J; Ou X; Dole M; Nuñez G
    Am J Pathol; 1993 Dec; 143(6):1543-50. PubMed ID: 8256847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Competitive polymerase chain reaction for the determination of N-myc amplification in neuroblastoma: report of clinical cases.
    Hasan Z; Inoue A; Ikeda H; Kamii Y; Obana K; Yokomori K; Tsuchida Y; Hemmi H; Shimatake H
    Eur J Pediatr Surg; 1999 Jun; 9(3):138-41. PubMed ID: 10427487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multifocal neuroblastoma: biologic behavior and surgical aspects.
    Hiyama E; Yokoyama T; Hiyama K; Yamaoka H; Matsuura Y; Nishimura Si; Ueda K
    Cancer; 2000 Apr; 88(8):1955-63. PubMed ID: 10760774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distal chromosome 17 gains in neuroblastomas detected by comparative genomic hybridization (CGH) are associated with a poor clinical outcome.
    Brinkschmidt C; Christiansen H; Terpe HJ; Simon R; Lampert F; Boecker W; Dockhorn-Dworniczak B
    Med Pediatr Oncol; 2001 Jan; 36(1):11-3. PubMed ID: 11464859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.